Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 22, 2021 | Tavotek Biotherapeutics | $20.0M Series A | — | Lanhu Capital, New Alliance Capital, Oriza Holdings |
| Aug 1, 2018 | CureGenetics | $17.0M Series A | Qiming Venture Partners | Formic Ventures, Bill Gates, Scott Becker, Ascendin Investment |
| Jul 18, 2018 | Ascentage Pharma | $150.0M Series C | Teng Yue Partners, Lawrence Tian | ArrowMark Partners, CCB International, HDY International Investment |